Slynd and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Slynd (drospirenone) and Cymbalta (duloxetine hydrochloride). Common drug interactions include hypersensitivity among females.

The phase IV clinical study analyzes what interactions people have when they take Slynd and Cymbalta. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Slynd?

Slynd has active ingredients of drospirenone. It is often used in birth control. eHealthMe is studying from 1,658 Slynd users. Check the latest studies of Slynd.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

On Jul, 19, 2026

13 people who take Slynd and Cymbalta together, and have interactions are studied.

What are the common drug interactions of Slynd and Cymbalta, by gender? *:

female:

Hypersensitivity
Asthma exercise induced
Adjustment disorder with depressed mood
Blood triglycerides decreased
Blood triglycerides increased
Contusion (a type of hematoma of tissue in which capillaries)
Corneal abrasion (loss of the surface of cornea)
Dehydration (dryness resulting from the removal of water)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

male:

n/a

What are the common drug interactions of Slynd and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)

30-39:

Pain
Hypersensitivity
Injection site pain
Insomnia (sleeplessness)
Nasopharyngitis (inflammation of the nasopharynx)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 53.85%
Drowsiness: 6 people, 46.15%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 46.15%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 15.38%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 15.38%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 15.38%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 15.38%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 7.69%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 7.69%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Slynd and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously